Envision Healthcare (EVHC) Reports Q2 Adj. EPS of $0.85, Beats on Revenues; FY17 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Envision Healthcare (EVHC) PT Lowered to $57 at Mizuho Securities
August 9, 2017 1:17 PM EDTMizuho Securities lowered its price target on Envision Healthcare (NYSE: EVHC) to $57.00 (from $65.00) while maintaining a Neutral rating. Analyst Ann Hynes lowered the price target given the guidance reduction and headwinds in the physician services industry.
Mizuho believes that the... More
Envision Healthcare (EVHC) PT Lowered to $57 at Mizuho Securities on 2Q Report; 'Guidance Reduction & Headwinds in Physician Services Industry'
August 9, 2017 12:31 PM EDTMizuho Securities lowered its price target on Envision Healthcare (NYSE: EVHC) to $57.00 (from $65.00) while maintaining a Neutral rating, following the company's second quarter earnings report.
Analyst Ann Hynes notes the company delivered second quarter earnings per share results in above the Street's estimates on $1.95... More
